2004N-0133 - Part 11 Public Meeting; June 11, 2004
FDA Comment Number : EC16
Submitter : Mr. Peter Robertson Date & Time: 06/23/2004 06:06:57
Organization : AstraZeneca plc
International Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
Please see the attached script initially intended for submission at the Public Meeting.

AstraZeneca.
Alderley House
Alderley Park
Macclesfield,Cheshire
SK10 4TF